DNA hypomethylation, in combination with an activated Wnt pathway, enhances caspase-3 expression and apoptosis, potentially inhibiting intestinal tumorigenesis and offering new therapeutic insights in colorectal cancer (CRC)51. Here, CASP3 is linked to colorectal carcinoma.